- 专利标题: Purine derivatives as modulators of TNF activity
-
申请号: US15100697申请日: 2014-12-08
-
公开(公告)号: US09988383B2公开(公告)日: 2018-06-05
- 发明人: Victoria Elizabeth Jackson , Boris Kroeplien , Martin Alexander Lowe , John Robert Porter
- 申请人: UCB BIOPHARMA SPRL
- 申请人地址: BE Brussels
- 专利权人: UCB BIOPHARMA SPRL
- 当前专利权人: UCB BIOPHARMA SPRL
- 当前专利权人地址: BE Brussels
- 代理机构: McDonnell Boehnen Hulbert & Berghoff LLP
- 优先权: GB1321737.7 20131209
- 国际申请: PCT/EP2014/076843 WO 20141208
- 国际公布: WO2015/086505 WO 20150618
- 主分类号: C07D473/00
- IPC分类号: C07D473/00 ; C07D473/32 ; A61K31/5377
摘要:
A series of substituted purine derivatives, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
公开/授权文献
- US20160297818A1 Purine Derivatives As Modulators of TNF Activity 公开/授权日:2016-10-13
信息查询
IPC分类:
C | 化学;冶金 |
C07 | 有机化学 |
C07D | 杂环化合物(高分子化合物入C08) |
C07D473/00 | 含嘌呤环系的杂环化合物 |